Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma

We explored the hypothesis that sorafenib may improve the effect of transarterial chemoembolization (TACE) in patients with recurrent hepatocellular carcinoma (HCC) and that longer sorafenib duration was associated with additional survival benefits. In this retrospective, nested case-controlled stud...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Wan, Xuying, Zhai, Xiaofeng, Yan, Zhenlin, Yang, Pinghua, Li, Jun, Wu, Dong, Wang, Kui, Xia, Yong, Shen, Feng
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347807/
https://ncbi.nlm.nih.gov/pubmed/27566566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11514
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars